CIK 0000921114 · Non-accelerated filer<br>Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911549568
- Phone
- 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-26 | Innoviva, Inc. Director | Purchase | +1,867,912 | $3.25 | $6.1M | 1,867,912 |
| 2021-01-26 | Innoviva, Inc. Director | Purchase · Warrants to Purchase Common Stock | +1,867,912 | $3.25 | $6.1M | 1,867,912 |
| 2020-12-08 | Patrick Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-12-08 | PATTI JOSEPH M Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-12-08 | Peterson Todd C. Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-12-08 | Morris Duane Alfred VP of Operations | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-12-08 | Kramer Robin Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-12-08 | Martin Steven Robert Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-12-08 | Schlesinger Sarah J. Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-12-08 | Varnum Brian President and CDO | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-12-08 | BASTIANI RICHARD Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-12-08 | Odysseas Kostas D Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2020-03-27 | Innoviva, Inc. 10% owner | Purchase | +7,717,661 | $2.87 | $22.1M | 8,710,800 |
| 2020-03-27 | Innoviva, Inc. 10% owner | Purchase · Warrants to Acquire Common Stock | +7,717,661 | $2.87 | $22.1M | 8,710,800 |
| 2020-02-12 | Odysseas Kostas D Director | Grant or award · Stock Option (Right to Buy) | +27,383 | 27,383 | ||
| 2020-02-12 | Schlesinger Sarah J. Director | Grant or award · Stock Option (Right to Buy) | +27,383 | 27,383 | ||
| 2019-10-10 | Peterson Todd C. Director | Grant or award · Stock Option (Right to Buy) | +27,383 | 27,383 | ||
| 2019-05-22 | COOK JEREMY CURNOCK Director | Grant or award · Stock Option (Right to Buy) | +27,383 | 27,383 | ||
| 2019-05-22 | Bear Richard Director | Grant or award · Stock Option (Right to Buy) | +27,383 | 27,383 | ||
| 2019-05-22 | Martin Steven Robert Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +149,362 | 149,362 |
Page 5 of 7 · 122 trades